Li, Chengming, Zhu, Lei, Liang, Wenbo, Su, Rongchuan, Yin, Jiangliang, Hu, Yanmei, Lan, Yu, Wu, Di, and You, Jingsong
Divergent synthesis of meso-N/O-heteroarene-fused (quinoidal) porphyrins was established via rhodium-catalyzed β-C–H activation/annulation of quinoidal porphyrins with alkynes., Here we present a divergent synthesis of brand-new types of meso-N/O-heteroarene-fused (quinoidal) porphyrins through Rh-catalyzed β-C–H activation/annulation of 5,15-dioxoporphyrins and dioxime derivatives with alkynes, in which the synthetic disconnections are difficult to access through the commonly used intramolecular cyclization strategy. Using the O-methyl oxime as a traceless oxidizing directing group, the meso-N-embedded pyridine-fused anti-quinoidal porphyrin 3 and pyridinium-fused cation 4 are formed with controllable chemoselectivity and complete anti-selectivity. Replacing the exocyclic oxime with a carbonyl group delivers the pyran-fused porphyrin 5, achieving structural conversion from a quinoidal conformation to a stable porphyrin macrocycle. Further oxidation of the expanded dimer 5ea gives the oxonium 6, which exhibits intense near-infrared (NIR) Q-bands up to 1300 nm. Theoretical studies demonstrate that the incorporation of a heteroatom at the meso-position enables more effective π-extension, resulting in a 22π aromatic (vs. 18π aromatic) character of pyran-fused porphyrins (syn/anti-5aa). Compared with the commercially available methylene blue (MB), syn-5al exhibits a better ability (ΦΔ = 0.61) to sensitize singlet oxygen (1O2) when irradiated with a 680 nm laser beam, and has potential as a photodynamic therapy (PDT) photosensitizer in the body's therapeutic window (650–900 nm).